Cholecystitis as a Possible Immunologic Consequence of COVID-19; Case Series from a Large Healthcare System
Am J Med Sci
.
2022 May;363(5):456-458.
doi: 10.1016/j.amjms.2022.01.008.
Epub 2022 Jan 24.
Authors
Christopher Polk
1
,
Mindy Marie Sampson
2
,
Anna Jacobs
3
,
Banks Kooken
3
,
Tom Ludden
4
,
Catherine L Passaretti
2
,
Michael Leonard
4
Affiliations
1
Division of Infectious Diseases, Atrium Health, Charlotte, NC, USA. Electronic address: Christopher.Polk@atriumhealth.org.
2
Division of Infectious Diseases, Atrium Health, Charlotte, NC, USA.
3
Department of Medicine, Atrium Health, Charlotte, NC, USA.
4
Department of Family Medicine, Atrium Health, Charlotte, NC, USA.
PMID:
35085530
PMCID:
PMC8785331
DOI:
10.1016/j.amjms.2022.01.008
No abstract available
Publication types
Letter
MeSH terms
COVID-19*
Cholecystitis*
Delivery of Health Care
Humans
SARS-CoV-2